Brief: Bioxytran Receives Approval to Begin Trials with ProLectin-I In India
Feb 6 (Reuters) - Bioxytran Inc BIXT.PK :
* BIOXYTRAN INC - RECEIPT OF AN IND AUTHORIZATION LETTER
FROM
INDIA'S CENTRAL DRUGS STANDARD CONTROL ORGANIZATION TO EVALUATE
PROLECTIN-I INJECTION
Source text for Eikon: ID:nGNX5L8JYr
Further company coverage: BIXT.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bioxytran
See all newsUS officials pressed China on rare earths, farm goods commitments, Bessent says (updated)
Italy's Angelini Pharma completes $4.1 billion state-backed takeover of Catalyst (updated)
Italy's Angelini Pharma completes $4.1 billion state-backed takeover of Catalyst
Brief: Bioxytran Inc Reports Positive Phase 1B/2A Clinical Study Results For Prolectin-M, Broad-Range Antiviral Drug In Mild To Moderate Covid-19
Brief: Bioxytran Reports Positive Phase 2 Results Demonstrating Rapid Viral Clearance With Prolectin-Mbioxytran